Blog

US Stocks Industry Groups

IBD Industry Groups Bell Curve – Bullish Percent

The IBD Industry Groups Bell Curve declined by -6.50% this week, dropping back into the lower half of the Stage 1 zone (between 40% and 60%). The amount of groups in Stage 4 increased by +22 (+11%), and the amount of groups in Stage 2 decreased by -31 (-15.5%), while the amount groups in Stage 1 or Stage 3 increased by +9 (+4.5%).
Read More

Stage Analysis Members Video – 4 December 2022 (1hr 27mins)

The Stage Analysis members weekend video discussing the market indexes, Dollar index, commodities, industry groups relative strength, IBD industry group bell curve – bullish percent, market breadth charts to determine the weight of evidence, Stage 2 breakout attempts and the US watchlist stocks in detail on multiple timeframes.
Read More

IBD Industry Groups Bell Curve – Bullish Percent

The IBD Industry Groups Bell Curve gained +2.03% this week, moving it back above the 50% level to close at 51.66%, which is firmly in the Stage 1 zone, with the bell curve fairly evenly distributed in the middle of the range.
Read More

Stage Analysis Members Video – 27 November 2022 (1hr 24mins)

The Stage Analysis members weekend video discussing the market indexes, Dollar index, commodities, industry groups relative strength, IBD industry group bell curve – bullish percent, market breadth charts to determine the weight of evidence, this weeks Stage 2 breakout attempts and the US watchlist stocks in detail on multiple timeframes.
Read More

IBD Industry Groups Bell Curve – Bullish Percent

The IBD Industry Groups Bell Curve continued to consolidate for another week, with only a small gain of +0.30% to end the week at 49.63% over. So little change with it firmly in the middle of the range, and the majority of groups in the Stage 1 zone.
Read More

Stage Analysis Members Video – 20 November 2022 (1hr 32mins)

The members weekend video discussing the market indexes, industry groups relative strength, IBD industry group bell curve – bullish percent, market breadth charts to determine the weight of evidence, Stage 2 breakout attempts in multiple stocks and the US watchlist stocks in more detail.
Read More